2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

Faculty Disclosure Listing continued Haralambos Gavras, MD Advisor/Consultant: Medivation, Merck. Speakers’ Bureau/Speaking/ Teaching: Novartis. F. Wilford Germino, MD I have no relationships to disclose. Thomas D. Giles, MD Advisor/Consultant: Amylin, Forest, NiCox. Grant/Research Support: Forest. Speakers’ Bureau/Speaking/Teaching: Forest. Member, ASH Board of Directors. Chair, ASH Specialists Program Inc. Alan H. Gradman, MD Advisor/Consultant: Novartis, Forest, Takeda, Daiichi-Sankyo. Speakers’ Bureau/Speaking/Teaching: Novartis, Forest, Takeda. Member, ASH Board of Directors. Joey P. Granger, PhD I have no relationships to disclose. Richard H. Grimm, MD, PhD Advisor/Consultant: Abbott. Grant/Research Support: Roche. Speakers’ Bureau/Speaking/Teaching: Merck. Yuan Guo, MD, MS I have no relationships to disclose. John E. Hall, PhD I have no relationships to disclose. Joel Handler, MD I have no relationships to disclose. David Harder, MD, PhD I have no relationships to disclose. Raymond C. Harris, MD I have no relationships to disclose. David G. Harrison, MD Grant/Research Support: National Institutes of Health. Joseph A. Hill, MD I have no relationships to disclose. Norman K. Hollenberg, MD, PhD Advisor/Consultant: Novartis, Merck, Vitae Pharmaceuticals. Grant/ Research Support: Vitae Pharmaceuticals. Suzanne Hughes, MSN, RN I have no relationships to disclose. Joseph L. Izzo, Jr., MD Advisor/Consultant: Pharmacists Mutural, Boehringer-Ingelheim, Novartis, Curry Rockfeller, Thornton Medical, Daiichi-Sankyo, SCS Healthcare, Takeda, Maritz Travel Co. Grant/Research Support: Novartis, Daiichi-Sankyo. Speakers’ Bureau/Speaking/Teaching: Novartis, Daiichi-Sankyo, SCS Healthcare, Maritz Travel Co. Edgar A. Jaimes, MD Advisor/Consultant: Novartis. 148
Faculty Disclosure Listing continued Kenneth A. Jamerson, MD Advisor/Consultant: Boehringer-Ingelheim, Eli Lily, Daiichi-Sankyo, Novartis. Trustee/Board Member/Committee Member: American Society Of Hypertension, International Society of Hypertension in Blacks. Grant/Research Support: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Heart, Lung, and Blood Institute, Novartis. Speakers’ Bureau/ Speaking/Teaching: Daiichi-Sankyo. Julie A. Johnson, PharmD Advisor/Consultant: Medco. Richard J. Johnson, MD Grant/Research Support: National Institutes of Health. Other Relevant Financial Benefit or Relationship: Patent on the Use of Allopurinol to Treat Hypertension. Pedro A. Jose, MD Grant/Research Support: National Heart, Lung, and Blood Institute, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, BIAL. Ownership/Partnership or Principal of Non-Profit or for Profit Corporation: Hypogen, Inc. Luis I. Juncos, MD I have no relationships to disclose. Rae‐Ellen W. Kavey, MD, MPH I have no relationships to disclose. Donald E. Kohan, MD, PhD Advisor/Consultant: Abbott, Pfizer, Gilead, Bristol-Myers Squibb. Grant/Research Support: National Institutes of Health. VA, Gilead. David S. Kountz, MD I have no relationships to disclose. Lawrence R. Krakoff, MD I have no relationships to disclose. Henry Krum, MBBS Grant/Research Support: Ardian. Louis Kuritzky, MD Advisor/Consultant: Boehringer-Ingelheim, Takeda. Speakers’ Bureau/Speaking/Teaching: Boehringer-Ingelheim, Takeda. Theodore W. Kurtz, MD I have no relationships to disclose. Robert F. Kushner, MD I have no relationships to disclose. Daniel T. Lackland, DrPH Speakers’ Bureau/Speaking/Teaching: Sanofi-Aventis, Boehringer- Ingelheim. Member, ASH Board of Directors. Edward G. Lakatta, MD I have no relationships to disclose. Babbette LaMarca, PhD Grant/Research Support: American Heart Association, National Institutes of Health. Marc B. Lande, MD, MPH Grant/Research Support: National Institutes of Health. 149
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19:
2011 ASH Corporate Members Boehring
Page 20 and 21:
ASH Leadership 2010-2011 Board of D
Page 22 and 23:
Special Lecture Monday, May 23, 201
Page 24 and 25:
Young Scholar Award* Monday, May 23
Page 26 and 27:
Special Lecture Monday, May 23, 201
Page 28 and 29:
2011 Abstract Reviewers Lawrence J.
Page 30 and 31:
More than half of hypertensive pati
Page 32 and 33:
Poster Category Presentation Poster
Page 34 and 35:
2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37:
2011 ASH Faculty continued David L.
Page 38 and 39:
American Society of Hypertension, I
Page 40 and 41:
Program Color Key The pages of this
Page 42 and 43:
MAY 21 Saturday Morning Hypertensio
Page 44 and 45:
MAY 21 Sessions Saturday Afternoon
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
MAY 21 Posters Saturday Evening Pos
Page 52 and 53:
MAY 22 Sunday morning Sessions cont
Page 54 and 55:
MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57:
MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59:
MAY 22 Debates Sunday Morning 11:00
Page 60 and 61:
MAY 22 Plenary Session I Sunday Aft
Page 62 and 63:
MAY 22 Special Sessions Sunday Afte
Page 64 and 65:
MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67:
MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69:
MAY 23 Sessions Monday morning 8:00
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
MAY 23 Plenary Session II Monday Af
Page 80 and 81:
MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83:
MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85:
MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88:
2011 American Society of Hypertensi
Page 89 and 90:
Saturday Afternoon MAY 21 Posters 4
Page 91 and 92:
Saturday Afternoon MAY 21 Posters P
Page 93 and 94:
Saturday Afternoon MAY 21 Posters E
Page 95 and 96:
Page 97 and 98:
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 101 and 102: Saturday Afternoon MAY 21 Posters P
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 127 and 128: Monday Morning Afternoon MAY 21 23
Page 147 and 148: Faculty Disclosure Listing Rajiv Ag
Page 149: Faculty Disclosure Listing continue
Page 153 and 154: Faculty Disclosure Listing continue
Page 155 and 156: Faculty Disclosure Listing continue
Page 157 and 158: ASH Hypertension Resource Pavilion
Page 159 and 160: 2011 ASH Innovations Theater Rhinel
Page 161 and 162: 2011 ASH Exhibitors continued A & D
Page 163 and 164: 2011 ASH Exhibitors continued David
Page 165 and 166: 2011 ASH Exhibitors continued Inter
Page 167 and 168: 2011 ASH Exhibitors continued Novar
Page 169 and 170: 2011 ASH Exhibitors continued Wiley
Page 171 and 172: Author Index Berezina, Aelita V., 8
Page 173 and 174: Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176: Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178: Author Index Makani, Harikrishna, 1
Page 179 and 180: Author Index Rabelink, Ton J., 93 R
Page 181 and 182: Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184: Hilton New York Floor Plans Second
Page 185 and 186: Hilton New York Floor Plans Fourth
Page 187 and 188: Tekamlo (aliskiren and amlodipine)
Page 189 and 190: 25% (systolic) and 27% (diastolic)
Page 191 and 192: Two cases of angioedema with respir
Page 193 and 194: amlodipine and sildenafil were used
Page 195 and 196: Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?